Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia

Fellner, Lisa, Irschick, Regina, Schanda, Kathrin, Reindl, Markus, Klimaschewski, Lars, Poewe, Werner, Wenning, Gregor K., Stefanova, Nadia·2013·Glia
DOI 10.1002/glia.22437

Cited by (699)

Items 401–500 of 699

  1. Hepcidin-to-Ferritin Ratio Is Decreased in Astrocytes With Extracellular Alpha-Synuclein and Iron Exposure
    Juntao Cui, Xinli Guo, Qijun Li, Ning Song, Junxia Xie · 2020 · Frontiers in Cellular Neuroscience
  2. Porphyromonas gingivalis: A key role in Parkinson's disease with cognitive impairment?
    Dongcheng Li, Tengzhu Ren, Hao Li, Geng Liao, Xiong Zhang · 2022 · Frontiers in Neurology
  3. Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions
    Anna C. Stoll, Christopher J. Kemp, Joseph R. Patterson, Jacob W. Howe, Kathy Steece‐Collier, Kelvin C. Luk, Caryl E. Sortwell, Matthew J. Benskey · 2024 · Neurobiology of Disease
  4. Microglia-Synapse Pathways: Promising Therapeutic Strategy for Alzheimer’s Disease
    Jingdun Xie, Haitao Wang, Ting Lin, Bingtian Bi · 2017 · BioMed Research International
  5. Remodeling microglia to a protective phenotype in Parkinson’s disease?
    Ifeoluwa Oluleke Awogbindin, Ismail Ogunbayode Ishola, Marie‐Kim St‐Pierre, Micaël Carrier, Julie C. Savage, Thérèse Di Paolo, Marie‐Ève Tremblay · 2020 · Neuroscience Letters
  6. Astrocytes in Neurodegenerative Diseases: A Perspective from Tauopathy and α-Synucleinopathy
    Peng Wang, Yihong Ye · 2021 · Life
  7. Host oligodendrogliopathy and α-synuclein strains dictate disease severity in multiple system atrophy
    Teresa Torre-Muruzabal, Anke Van der Perren, Audrey Coens, Géraldine Gelders, Anna Barber Janer, Sara Camacho-Garcia, Therése Klingstedt, K. Peter R. Nilsson, Nadia Stefanova, Ronald Melki et al. · 2022 · Brain
  8. How Toll-like receptors influence Parkinson’s disease in the microbiome–gut–brain axis
    Ziyi Zhang, Zhihui Liu, Ao Lv, Chenhui Fan · 2023 · Frontiers in Immunology
  9. Cellular processing of α-synuclein fibrils results in distinct physiological C-terminal truncations with a major cleavage site at residue Glu 114
    Stephan S. Quintin, Grace M. Lloyd, Giavanna Paterno, Yuxing Xia, Zachary A. Sorrentino, Brach M. Bell, Kimberly-Marie M. Gorion, Edward B. Lee, Stefan Prokop, Benoit I. Giasson · 2023 · Journal of Biological Chemistry
  10. Sex and Age Differences in a Progressive Synucleinopathy Mouse Model
    Jérôme Lamontagne‐Proulx, Katherine Coulombe, Marc Morissette, Marie Rieux, Frédéric Calon, Thérèse Di Paolo, Denis Soulet · 2023 · Biomolecules
  11. Investigation of Inflammation in Lewy Body Dementia: A Systematic Scoping Review
    Paula M. Loveland, Jenny Jia Yu, Leonid P. Churilov, Nawaf Yassi, Rosie Watson · 2023 · International Journal of Molecular Sciences
  12. Emerging roles of protein kinases in microglia-mediated neuroinflammation
    Sun Hwa Lee, Kyoungho Suk · 2017 · Biochemical Pharmacology
  13. The Role of Intermittent Fasting in Parkinson's Disease
    Bryan J. Neth, Brent A. Bauer, Eduardo Elias Benarroch, Rodolfo Savica · 2021 · Frontiers in Neurology
  14. Epothilone D inhibits microglia-mediated spread of alpha-synuclein aggregates
    Valdinocci, Dario, Grant, Gary D., Dickson, Tracey C., Pountney, Dean L. · 2018 · Molecular and Cellular Neuroscience
  15. Innate and adaptive immunity in neurodegenerative disease
    Yeyu Huang, Guoxin Zhang, Sheng Li, Jin Feng, Zhentao Zhang · 2025 · Cellular and Molecular Life Sciences
  16. Extract of Fructus Schisandrae chinensis Inhibits Neuroinflammation Mediator Production from Microglia via NF-κ B and MAPK Pathways
    Fangjiao Song, Ke‐Wu Zeng, Jinfeng Chen, Yuan Li, Xiaomin Song, Pengfei Tu, Xuemei Wang · 2018 · Chinese Journal of Integrative Medicine
  17. Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease
    Yong Hui Koh, Li Yi Tan, Shi‐Yan Ng · 2018 · Frontiers in Cellular Neuroscience
  18. Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy
    Karen M. Delgado-Minjares, Daniel Martínez‐Fong, Irma Alicia Martínez-Dávila, Cecilia Bañuelos, María Eugenia Gutiérrez-Castillo, Víctor Manuel Blanco-Álvarez, María del Carmen Cárdenas‐Aguayo, José Luna‐Muñoz, Mar Pacheco‐Herrero, Luis Oskar Soto-Rojas · 2021 · International Journal of Molecular Sciences
  19. Mechanisms of Autoimmune Cell in DA Neuron Apoptosis of Parkinson’s Disease: Recent Advancement
    Zijian Zheng, Shushan Zhang, Hanwen Zhang, Zhongzheng Gao, Xiangrong Wang, Xinjie Liu, Xue Cheng, Longping Yao, Guohui Lu · 2022 · Oxidative Medicine and Cellular Longevity
  20. Toll Like Receptor 4 Affects the Cerebral Biochemical Changes Induced by MPTP Treatment
    Carmela Conte, Luca Roscini, Roccaldo Sardella, Giuseppina Mariucci, Stefania Scorzoni, Tommaso Beccari, Laura Corte · 2017 · Neurochemical Research
  21. Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human α-synuclein
    Zuzana Krejciova, George A. Carlson, Kurt Giles, Stanley B. Prusiner · 2019 · Acta Neuropathologica Communications
  22. MSA: From basic mechanisms to experimental therapeutics
    Antonio Heras‐Garvin, Nadia Stefanova · 2020 · Parkinsonism & Related Disorders
  23. High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy
    Antonio Heras‐Garvin, Violetta Refolo, Markus Reindl, Gregor Karl Wenning, Nadia Stefanova · 2020 · Journal of Neuroinflammation
  24. What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson’s Disease?
    Amaryllis E. Hill, Richard Wade‐Martins, Philip W. J. Burnet · 2021 · Frontiers in Neuroscience
  25. Rapid Induction of Dopaminergic Neuron Loss Accompanied by Lewy Body-Like Inclusions in A53T BAC-SNCA Transgenic Mice
    Shinya Okuda, Norihito Uemura, Masanori Sawamura, Tomoyuki Taguchi, Masashi Ikuno, Maiko T. Uemura, Hodaka Yamakado, Ryōsuke Takahashi · 2021 · Neurotherapeutics
  26. The Innate and Adaptive Immune Cells in Alzheimer’s and Parkinson’s Diseases
    Boyuan Huang, Yan Zhenxin, Sisi Chen, Zhenhua Tan, Zhitao Zong, Hongbo Zhang, Xiaoxing Xiong · 2022 · Oxidative Medicine and Cellular Longevity
  27. The interplay between neuroinflammatory pathways and Parkinson's disease
    Pınar Eser Ocak, Ersoy Kocabıçak, Ahmet Bekâr, Yasin Temel · 2023 · Experimental Neurology
  28. Targeting α-synuclein as a therapeutic strategy for Parkinson’s disease
    Nada Lawand, Nayef E. Saadé, Omar M. A. El‐Agnaf, Bared Safieh‐Garabedian · 2015 · Expert Opinion on Therapeutic Targets
  29. Innate immune response to lipooligosaccharide: pivotal regulator of the pathobiology of invasive Neisseria meningitidis infections
    Constance M. John, Nancy J. Phillips, Daniel C. Stein, Gary A. Jarvis · 2017 · Pathogens and Disease
  30. Models of Multiple System Atrophy
    Lisa Fellner, Gregor Karl Wenning, Nadia Stefanova · 2013 · Current topics in behavioral neurosciences
  31. Parkinson's Disease and the Microbiota-Gut-Brain Axis: Metabolites, Mechanisms, and Innovative Therapeutic Strategies Targeting the Gut Microbiota
    Ran Zhao, Benrong Mu, Dongmei Wang, XinHuang, Quanhong Ma, Mei‐Hong Lu · 2024 · Molecular Neurobiology
  32. Potential for Therapeutic-Loaded Exosomes to Ameliorate the Pathogenic Effects of α-Synuclein in Parkinson’s Disease
    David J. Rademacher · 2023 · Biomedicines
  33. Increased tyrosine hydroxylase expression accompanied by glial changes within the non-lesioned hemisphere in the 6-hydroxydopamine model of Parkinson's disease
    Johannes C. M. Schlachetzki, Franz Marxreiter, Martin Regensburger, Anna O. Kulinich, Beate Winner, Jürgen Winkler · 2014 · Restorative Neurology and Neuroscience
  34. Current experimental disease-modifying therapeutics for multiple system atrophy
    Miguel Lemos, Gregor Karl Wenning, Nadia Stefanova · 2021 · Journal of Neural Transmission
  35. Unraveling Parkinson's disease: The mystery of mitochondria and the role of aging
    Tingting Liu, Jingwen Li, Haojie Wu, Junbo Qiao, Jianshe Wei · 2025 · Genes & Diseases
  36. Modulating neuroinflammation in neurodegeneration-related dementia: can microglial toll-like receptors pull the plug?
    Rohit Kumar Tiwari, Afrasim Moin, Syed Mohd Danish Rizvi, Syed Monowar Alam Shahid, Preeti Bajpai · 2021 · Metabolic Brain Disease
  37. Emerging role of microglia in inter-cellular transmission of α-synuclein in Parkinson’s disease
    Xiangbo Zhang, Haiyang Yu, Juan Feng · 2024 · Frontiers in Aging Neuroscience
  38. Association Between Toll‐Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Genetic Variants and Clinical Progression of Huntington's Disease
    Romina Vuono, Antonina Kouli, Emilie M. Legault, Lauriane Chagnon, Kieren S. J. Allinson, Alberto Spada, REGISTRY Investigators of the European Huntington's Disease Network, Ida Biunno, Roger A. Barker, Janelle Drouin‐Ouellet · 2019 · Movement Disorders
  39. Potential Use of Nanomedicine for the Anti-inflammatory Treatment of Neurodegenerative Diseases
    María Dolores Cayero Otero, Ana M. Espinosa‐Oliva, Antonio J. Herrera, Irene García-Domínguez, Mercedes Fernández Arévalo, Lucía Martín‐Banderas, Rocío M. de Pablos · 2018 · Current Pharmaceutical Design
  40. Prothrombin Kringle-2: a potential inflammatory pathogen in the parkinsonian dopaminergic system
    Leem, Eunju, Jeong, Kyoung Hoon, Won, So-Yoon, Shin, Won-Ho, Kim, Sang Ryong · 2016 · Experimental Neurobiology
  41. Ammonia induces amyloidogenesis in astrocytes by promoting amyloid precursor protein translocation into the endoplasmic reticulum
    Ayaka Komatsu, Izumi Iida, Yusuke Nasu, Genki Ito, Fumiko Harada, Sari Kishikawa, Stephen J. Moss, Takeyasu Maeda, Miho Terunuma · 2022 · Journal of Biological Chemistry
  42. MicroRNAs Dysregulation and Metabolism in Multiple System Atrophy
    Chunchen Xiang, Shunchang Han, Jianfei Nao, Shuyan Cong · 2019 · Frontiers in Neuroscience
  43. Extracellular Alpha-Synuclein Promotes a Neuroinhibitory Secretory Phenotype in Astrocytes
    Bruno Di Marco Vieira, Rowan A. W. Radford, Junna Hayashi, Emma D. Eaton, Ben Greenaway, Mark Jambas, Eugen Bogdan Petcu, Roger S. Chung, Dean L. Pountney · 2020 · Life
  44. The neuroinflammatory role of glucocerebrosidase in Parkinson's disease
    Ruxue Bo, Yanyan Li, Tian-Tian Zhou, Nai‐Hong Chen, Yu‐He Yuan · 2022 · Neuropharmacology
  45. Single-nucleus transcriptomics reveals a distinct microglial state and increased MSR1-mediated phagocytosis as common features across dementia subtypes
    Chia, Sook-Yoong, Li, Mengwei, Li, Zhihong, Tu, Haitao, Lee, Jolene Wei Ling, Qiu, Lifeng, Ling, Jingjing, Reynolds, Richard, Albani, Salvatore, Tan, Eng-King et al. · 2025 · Genome Medicine
  46. TLR4 and TLR2 activation is differentially associated with age during Parkinson’s disease
    Hermínio Maurício da Rocha Sobrinho, Delson José da Silva, Larissa Fonseca Gomides, Miriam Leandro Dorta, Milton Adriano Pelli de Oliveira, Fátima Ribeiro‐Dias · 2017 · Immunological Investigations
  47. Protein network exploration prioritizes targets for modulating neuroinflammation in Parkinson’s disease
    Marie-Amandine Bonte, Fatima El Idrissi, Bernard Gressier, David Devos, Karim Bélarbi · 2021 · International Immunopharmacology
  48. Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease
    Elena Coccia, Tim Ahfeldt · 2021 · Stem Cell Research & Therapy
  49. A functional role for alpha-synuclein in neuroimmune responses
    Dustin L. Heiden, Brendan Monogue, Muhammad Ali, John David Beckham · 2023 · Journal of Neuroimmunology
  50. The Absence of Toll-Like Receptor 4 Mildly Affects the Structure and Function in the Adult Mouse Retina
    Agustina Noailles, Oksana Kutsyr, Victoria Maneu, Isabel Ortuño‐Lizarán, Laura Campello, Emilio de Juan, Violeta Gómez‐Vicente, Nicolás Cuenca, Pedro Lax · 2019 · Frontiers in Cellular Neuroscience
  51. A Propagated Skeleton Approach to High Throughput Screening of Neurite Outgrowth for In Vitro Parkinson’s Disease Modelling
    Justus Schikora, Nina Kiwatrowski, Nils Förster, Leonie Selbach, Friederike Ostendorf, Frida Pallapies, Britta Hasse, Judith Metzdorf, Ralf Gold, Axel Mosig A et al. · 2021 · Cells
  52. Infections in the Etiology of Parkinson’s Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic Implications
    Gabriela Mercado, Christopher Käufer, Franziska Richter, Wouter Peelaerts · 2024 · Journal of Parkinson s Disease
  53. The Multifaceted Role of LRRK2 in Parkinson’s Disease
    Dong Hwan Ho, Sun Jung Han, Ilhong Son · 2025 · Brain Sciences
  54. The microglial P2Y6 receptor as a therapeutic target for neurodegenerative diseases
    Jacob M. Dundee, Guy Charles Brown · 2024 · Translational Neurodegeneration
  55. The microbiota-gut-brain axis: a potential target in the small-molecule compounds and gene therapeutic strategies for Parkinson’s disease
    Fengjuan Jiao, Lincong Zhou, Zhao Wu · 2024 · Neurological Sciences
  56. In vitro models of multiple system atrophy from primary cells to induced pluripotent stem cells
    Elena Abati, Alessio Di Fonzo, Stefania Paola Corti · 2018 · Journal of Cellular and Molecular Medicine
  57. α -Synuclein Trafficking in Parkinson’s Disease: Insights From Fly and Mouse Models
    Jingjing Cheng, Qingqing Lu, Song Li, Margaret Su-chun Ho · 2018 · ASN NEURO
  58. The Astrogenic Balance in the Aging Brain
    Fotis Andromidas, Saeid Atashpanjeh, Abigail J. Myers, Brooke MacKinnon, Melanie M. Shaffer, Andrew O. Koob · 2021 · Current Neuropharmacology
  59. The molecular mechanism of polygalasaponin F-mediated decreases in TNFα: emphasizing the role of the TLR4-PI3K/AKT-NF-κB pathway
    Wen-Fen Yan, Qian-Hang Shao, Dongming Zhang, Yu‐He Yuan, Nai‐Hong Chen · 2015 · Journal of Asian Natural Products Research
  60. The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson’s disease
    Yan Shen, Xingfang Guo, Chao Han, Fang Jung Wan, Kai Ma, Shiyi Guo, Luxi Wang, Yun Fei Xia, Ling Liu, Zhicheng Lin et al. · 2017 · Cellular and Molecular Life Sciences
  61. Limited effects of dysfunctional macroautophagy on the accumulation of extracellularly derived α-synuclein in oligodendroglia: implications for MSA pathogenesis
    Lisa Fellner, Edith Buchinger, Dominik Brück, Regina Irschick, Gregor Karl Wenning, Nadia Stefanova · 2018 · BMC Neuroscience
  62. Peripheral–central immune interactions in Parkinson’s disease: insights into innate and adaptive immunity
    Jarika Jahan Tumpa, Qurat Ul Ain Hayder, Nowshin Sharmily Maisa, Md. Nazmul Islam · 2025 · Frontiers in Molecular Neuroscience
  63. Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease
    Carmen Costas‐Ferreira, L.R.F. Faro · 2021 · Current Neuropharmacology
  64. What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson’s Disease?
    Jinsong Xue, Keju Tao, Weijia Wang, Xiaofei Wang · 2024 · International Journal of Molecular Sciences
  65. Allopregnanolone and its antagonist modulate neuroinflammation and neurological impairment
    Torbjörn Carl Bäckström, Magnus Doverskog, Thomas P. Blackburn, Bruce F. Scharschmidt, Vicente Felipo · 2024 · Neuroscience & Biobehavioral Reviews
  66. Microglia in Neurodegenerative Diseases
    Ifeoluwa Oluleke Awogbindin, Michael Wanklin, Alexei Verkhratsky, Marie‐Ève Tremblay · 2024 · Advances in neurobiology
  67. MMP13 Expression Is Increased Following Mutant α-Synuclein Exposure and Promotes Inflammatory Responses in Microglia
    Kathryn E. Sánchez, Kathleen A. Maguire‐Zeiss · 2020 · Frontiers in Neuroscience
  68. Synucleinopathies Take Their Toll: Are TLRs a Way to Go?
    Gabriella Margherita Mazzotta, Nadia Ceccato, Carmela Conte · 2023 · Cells
  69. Role of Telomeres and Telomerase in Parkinson's Disease—A New Theranostics?
    Balachandar Vellingiri, Kiruthika Balasubramani, Mahalaxmi Iyer, Neethu Raj, Ajay Elangovan, Kwonwoo Song, Han Cheol Yeo, Namitha Jayakumar, Masako Kinoshita, Thangarasu Ravimanickam et al. · 2023 · Advanced Biology
  70. TNFα inhibitors as targets for protective therapies in MSA: a viewpoint
    Alain Ndayisaba, K. A. Jellinger, Thomas Berger, Gregor Karl Wenning · 2019 · Journal of Neuroinflammation
  71. MIMOSA PUDICA EXERTS NEUROPROTECTION AGAINST MPP+INDUCED NEUROTOXICITY IN SHSY5Y CELL LINES-AN IN VITRO MODEL OF ANTI-PARKINSONISM
    Mahadevan M. V., Ramakrishna Ramaswamy, V. Banumathi · 2016 · International Journal of Pharmacy and Pharmaceutical Sciences
  72. Translational therapies for multiple system atrophy: Bottlenecks and future directions
    Stefanova, Nadia · 2018 · Autonomic Neuroscience
  73. Microglia in the crosstalk between peripheral and central nervous systems in Parkinson’s disease
    Tianbai Li, Tao Qiu, Fei Jiang, Huaibin Cai, Weidong Le · 2025 · Translational Neurodegeneration
  74. Desferrioxamine Ameliorates Lipopolysaccharide-Induced Lipocalin-2 Upregulation via Autophagy Activation in Primary Astrocytes
    Juntao Cui, Yuan Yu, Jun Wang, Ning Song, Junxia Xie · 2022 · Molecular Neurobiology
  75. CXCR4 knockout induces neuropathological changes in the MPTP-lesioned model of Parkinson's disease
    Jianjun Ma, Linrui Dong, Qingqing Chang, Siyuan Chen, Jinhua Zheng, Dongsheng Li, Shaopu Wu, Hongqi Yang, Xue Li · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  76. Uptake of alpha‐synuclein preformed fibrils is suppressed by inflammation and induces an aberrant phenotype in human microglia
    Jonna Niskanen, Sanni Peltonen, Sohvi Ohtonen, Mohammad Feroze Fazaludeen, Kelvin C. Luk, Luca Giudice, Jari Koıstınaho, Tarja Malm, Gundars Goldsteins, Katrina Albert et al. · 2024 · Glia
  77. Lewy body diseases and the gut
    Timothy Robert Sampson, Malú G. Tansey, Andrew B. West, Rodger A. Liddle · 2025 · Molecular Neurodegeneration
  78. Therapeutic Mechanisms of Exercise in Parkinson’s Disease
    Alice C. Wilson, Dean L. Pountney, Tien Kheng Khoo · 2025 · International Journal of Molecular Sciences
  79. Glial phagocytosis for synapse and toxic proteins in neurodegenerative diseases
    Yeseong Choi, Won‐Suk Chung · 2025 · Molecular Neurodegeneration
  80. The Synucleins and the Astrocyte
    Abigail J. Myers, Ayat Brahimi, Imani J. Jenkins, Andrew O. Koob · 2023 · Biology
  81. Glycation of alpha-synuclein enhances aggregation and neuroinflammatory responses
    Eftychia Vasili, Annekatrin König, Mohammed Al‐Azzani, Clara Bosbach, Luisa Maria Gatzemeier, Searlait Thom, Ana Chegão, Hugo Vicente Miranda, Claudia Steinem, Daniel Erskine et al. · 2025 · npj Parkinson s Disease
  82. Impact of monomeric and aggregated wild‐type and A30P/A53T double‐mutant α‐synuclein on antioxidant mechanism and glutamate metabolic profile of cultured astrocytes
    Aishwarya Raj, Alka Kaushal, Indrani Datta · 2021 · Journal of Neuroscience Research
  83. RGS10 mitigates high glucose-induced microglial inflammation via the reactive oxidative stress pathway and enhances synuclein clearance in microglia
    Jaegwon Chung, Janna E. Jernigan, Kelly B. Menees, Jae‐Kyung Lee · 2024 · Frontiers in Cellular Neuroscience
  84. The mechanisms of white matter injury and immune system crosstalk in promoting the progression of Parkinson’s disease: a narrative review
    Wen Ma, Yifan Geng, Youhan Liu, Huixin Pan, Qinglu Wang, Yaohua Zhang, Liping Wang · 2024 · Frontiers in Aging Neuroscience
  85. β-Synuclein Intermediates α-Synuclein Neurotoxicity in Parkinson’s Disease
    Meiyan Xian, Jingwen Li, Tingting Liu, Kaiying Hou, Lin Sun, Jianshe Wei · 2024 · ACS Chemical Neuroscience
  86. Advancements in understanding substantia nigra hyperechogenicity via transcranial sonography in Parkinson’s disease and its clinical implications
    Yuan-yuan Zhang, Xuhong Jiang, Pei-pei Zhu, Wenyan Zhuo, Li-bin Liu · 2024 · Frontiers in Neurology
  87. Astrocytes, a Promising Opportunity to Control the Progress of Parkinson’s Disease
    Alberto Sánchez, Ingrid Moráles, Clara Rodriguez‐Sabate, Miguel Solé-Sabater, Manuel Rodrı́guez · 2021 · Biomedicines
  88. X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B
    Christine A. Vaine, David S. Shin, Christina H. Liu, William T. J. Hendriks, Jyotsna Dhakal, Kyle Shin, Nutan Sharma, D. Cristopher Bragg · 2016 · Neurobiology of Disease
  89. Cytokine–Microglia Interactions in Neuroinflammation: Mechanisms, Disease Dynamics, and Therapeutic Strategies
    Fumei Zhang, Wenren Yang, Rong Sun, Xiaoyu Duan, 杨云华, Aiping Wang, Ying Tian · 2025 · Antioxidants and Redox Signaling
  90. Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies
    Chiara Sanluca, P. Spagnolo, Romina Mancinelli, Maria Ilenia De Bartolo, Marina Fava, Mauro Maccarrone, Simone Carotti, Eugenio Gaudio, Alessandro Leuti, Giorgio Vivacqua · 2024 · Metabolites
  91. Imaging flow cytometry reveals LPS-induced changes to intracellular intensity and distribution of α-synuclein in a TLR4-dependent manner in STC-1 cells
    Anastazja M. Gorecki, Chidozie C. Anyaegbu, Melinda Fitzgerald, Kathryn A. Fuller, Ryan S. Anderton · 2024 · Methods
  92. Perspective insights and application of exosomes as a novel tool against neurodegenerative disorders: An expository appraisal
    Amey Kadbhane, Monica Patel, Saurabh Srivastava, Pankaj Kumar Singh, Jitender Madan, Shashi Bala Singh, Dharmendra Kumar Khatri · 2021 · Journal of Drug Delivery Science and Technology
  93. Leucine-rich repeat kinase 2-related functions in GLIA: an update of the last years
    Alice Filippini, Massimo Gennarelli, Isabella Russo · 2021 · Biochemical Society Transactions
  94. Neurodegenerative Aspects of Multiple System Atrophy
    Rowan A. W. Radford, Mathew B. Wong, Dean L. Pountney · 2014 · Springer eBooks
  95. Differences in Retinal and Choroidal Microvasculature and Structure in Dementia With Lewy Bodies Compared With Normal Cognition
    Suzanna Joseph, Cason B. Robbins, Ariana Allen, Alice Haystead, Angela Hemesath, Anita Kundu, Justin P. Ma, Kim G. Johnson, Rupesh V. Agrawal, Vithiya Gunasan et al. · 2023 · Journal of VitreoRetinal Diseases
  96. Alpha-synuclein shapes monocyte and macrophage cell biology and functions by bridging alterations of autophagy and inflammatory pathways
    Fiona Limanaqi, Silvia Zecchini, Pasquale Ogno, Valentina Artusa, Claudio Fenizia, Irma Saulle, Claudia Vanetti, Micaela Garziano, Sergio Strizzi, Daria Trabattoni et al. · 2024 · Frontiers in Cell and Developmental Biology
  97. Microglial Melatonin Receptor 1 Degrades Pathological Alpha‐Synuclein Through Activating LC3 ‐Associated Phagocytosis In Vitro
    Xiao‐Yu Yao, Bing‐Er Cao, Junyi Liu, Qian-Kun Lv, Jiarui Zhang, Xiao‐Yu Cheng, Chengjie Mao, Quanhong Ma, Fen Wang, Chun‐Feng Liu · 2024 · CNS Neuroscience & Therapeutics
  98. Protective Effect of CP690550 in MPTP-Induced Parkinson’s Like Behavioural, Biochemical and Histological Alterations in Mice
    Abdulrahman Alshammari, Metab Alharbi, Norah Abdullah Albekairi, Thamer H. Albekairi, Omar Obaid Alharbi, Pravin Yeapuri, Sanjiv Singh · 2022 · Neurotoxicity Research
  99. Sodium chloride-induced changes in oxidative stress, inflammation, and dysbiosis in experimental multiple sclerosis
    Francisco A. Martín-Hersog, Ana Muñoz-Jurado, Begoña M. Escribano, Evelio Luque, Alberto Galván, Manuel LaTorre, Ana I. Giraldo, Javier Caballero‐Villarraso, Eduardo Agüera, Abel Santamarı́a et al. · 2022 · Nutritional Neuroscience
  100. Neurodegenerative diseases
    Alexei Verkhratsky, Arthur Morgan Butt · 2023 · Elsevier eBooks